ChristopherDKoprowskiMDMBA

Radiation Oncology • Newark, DE

Chair Radiation Oncology Department Helen F Graham Cancer Center

Join to view full profile

Dr. Koprowski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Koprowski's full profile

Already have an account?

Office
4701 Ogletown Stanton Rd
Ste 1109
Newark, DE 19713
Phone+1 302-623-4800

Fax+1 302-623-4850

Education & Training

Drexel University College of Medicine/Hahnemann University HospitalResidency, Radiation Oncology, 1986 - 1989
University of Pennsylvania Health SystemResidency, Neurology, 1978 - 1983
University of ChicagoInternship, Internal Medicine, 1977 - 1978
Lewis Katz School of Medicine at Temple UniversityClass of 1977

Certifications & Licensure

DE State Medical License 2002 - 2025
PA State Medical License 1979 - 2018
MD State Medical License 2002 - 2016
NJ State Medical License 1989 - 2003
American Board of Psychiatry and Neurology Neurology
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC.
Joanne B Weidhaas, Chen Hu, Ritsuko Komaki, Gregory A Masters, George R Blumenschein
Cancer Research Communications. 2023-10-11
49 citations
Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617.
Jian-Yue Jin, Chen Hu, Ying Xiao, Hong Zhang, Rebecca Paulus
Cancers. 2021-12-08
274 citations
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.
Jeffrey D. Bradley, Chen Hu, Ritsuko Komaki, Gregory A. Masters, George R. Blumenschein
Journal of Clinical Oncology. 2020-03-01

Press Mentions

Diagnosed with Breast Cancer - AgainOctober 19th, 2015